Cyclin D1, a Novel Molecular Marker of Minimal Residual Disease, in Metastatic Neuroblastoma
- 30 April 2007
- journal article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 9 (2) , 237-241
- https://doi.org/10.2353/jmoldx.2007.060130
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Database of mRNA gene expression profiles of multiple human organsGenome Research, 2005
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Measuring circulating neuroblastoma cells by quantitative reverse transcriptase–polymerase chain reaction analysisCancer, 2004
- Cyclin D1, p53, and p21Waf1/Cip1 Expression Is Predictive of Poor Clinical Outcome in Serous Epithelial Ovarian CancerClinical Cancer Research, 2004
- Overexpression of Cyclin D1 Is Associated with Poor Survival in Epithelial Ovarian CancerOncology, 2004
- Profiling and functional annotation of mRNA gene expression in pediatric rhabdomyosarcoma and Ewing's sarcomaInternational Journal of Cancer, 2004
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- Early Molecular Response of Marrow Disease to Biologic Therapy Is Highly Prognostic in NeuroblastomaJournal of Clinical Oncology, 2003
- Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastomaGenes, Chromosomes and Cancer, 2003
- Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reactionEuropean Journal of Cancer and Clinical Oncology, 1991